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ABSTRACT 
Objective 
Monitoring the administration of drugs and adverse drug reactions are key parts of 
pharmacovigilance. In this paper, we explore the extraction of drug mentions and drug-related 
information (reason for taking a drug, route, frequency, dosage, strength, form, duration, and 
adverse events) from hospital discharge summaries through deep learning that relies on various 
representations for clinical named entity recognition.  
Materials and Methods 
This work was officially part of the 2018 n2c2 shared task, and we use the data supplied as part 
of the task. We developed two deep learning architecture based on recurrent neural networks and 
pre-trained language models. We also explore the effect of augmenting word representations with 
semantic features for clinical named entity recognition. Our feature-augmented BiLSTM-CRF 
model performed with F1-score of 92.67% and ranked 4th for entity extraction sub-task among 
submitted systems to n2c2 challenge.  
Results 
The recurrent neural networks that use the pre-trained domain-specific word embeddings and a 
CRF layer for label optimization perform drug, adverse event and related entities extraction with 
micro-averaged F1-score of over 91%. The augmentation of word vectors with semantic features 
extracted using available clinical NLP toolkits can further improve the performance.  
Conclusion 
Word embeddings that are pre-trained on a large unannotated corpus of relevant documents and 
further fine-tuned to the task perform rather well. However, the augmentation of word 
embeddings with semantic features can help improve the performance (primarily by boosting 
precision) of drug-related named entity recognition from electronic health records. 
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INTRODUCTION 
Almost half of the British population take prescribed medications, and many people take multiple 
drugs simultaneously. Over 20% of adults are administered with five or more drugs [1]. Drug-
drug interactions and potential adverse drug events (ADEs) are not uncommon: ADEs caused by 
drug-drug interactions account for more than 30% of reported adverse drug reactions [2]. The 
quality of life and response to treatments are often affected by adverse drug reactions [3] and 
around 7% of hospital admissions are attributed to adverse drug events [2].  
Many adverse drug events, especially those that occur infrequently, cannot be predicted by 
toxicological testing on animals and controlled clinical trials on humans [4]. This monitoring has 
to be extended beyond the period of drug testing and clinical trials. Hospital discharge summaries 
present a potentially valuable source of information for monitoring drug and treatment 
administration and associated adverse drug events. Discharge summaries typically outline the 
patient's complaint at admission, diagnostic findings, therapy administered, the patient's response 
to the therapy, and recommendations on discharge. However, they are formatted as unstructured 
textual documents, requiring clinical natural language processing (NLP) to extract information of 
interest from free-text summaries. Recognition of clinical entities from unstructured documents is 
still an active research area [5-9], with recent advances in neural network architectures for NLP, 
such as language models and recurrent neural networks demonstrating improved performances 
form many tasks. 
To assess the current state of the art, the 2018 National NLP Clinical Challenge (n2c2) track 2 
aimed to evaluate the entity recognition subtask focused on identifying drugs and related entities 
(reason, route, frequency, dosage, strength, form, duration, and ADE) from discharge summaries. 
In this paper, we examine the efficiency of a framework we developed for the task, including the 
effect of augmenting pre-trained domain word embeddings with semantic features in order to 
improve the performance of clinical named entities recognition. The effects of semantic feature 
augmentation were evaluated on randomly initialised embeddings as well as on embeddings pre-
trained on MIMIC-III data. The proposed architecture has been officially evaluated as part of the 
n2c2 challenge. 
 
RELATED WORK 
There have been several approaches proposed to extract drug names and drug attributes from 
free-text data. Several rule-based methods have been developed using semantic lexicons to 
extract drugs and related information from biomedical publications [10], social media [11, 12] 
and electronic health records [13-19]. Earlier machine-learning studies employed traditional 
approaches [10, 20-22] such as conditional random fields (CRFs) for extracting entities and 
support vector machine (SVM) for relation extraction between them. More recently, deep 
learning models, particularly the recurrent neural network (RNN) models, attracted much 
attention in the NLP community. The majority of methods use word embeddings, generated by 
training a language model on a large corpus of unannotated domain-specific documents [23, 24]. 
They could be utilised as initial word representations and then fine-tuned for a specific clinical 
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entity recognition task [25-28], so that the final target model could benefit from large amounts of 
unannotated data, making task-specific learning more efficient. Feature augmentation is a method 
that aims to improve word representations learnt by a neural network by combining them with 
human-engineered features. Lee et al. [29] demonstrated that performance of their text de-
identification method (i.e. recognition of personal identifiable entities in discharge summaries) is 
improved when word embeddings are concatenated with the features representations learnt with 
the feedforward neural network. 
Several shared tasks for extraction of drug-related information have been organised. For example, 
the 3rd i2b2 shared task in 2009 focused on the identification of medication mentions in 
discharge summaries, along with associated attributes - dosages, modes of administration, 
frequency, duration, and reasons for prescriptions [14]. More recently, the Medication and 
Adverse Drug Events from Electronic Health Records (MADE) shared-task has been organised to 
detect medications and adverse drug events in electronic health records (EHRs) [30]. The target 
entities comprise drug name, dosage, route, duration, frequency, indication, ADE, and other signs 
and symptoms. In addition to training data, participants were provided with pre-trained word 
embedding trained using Wikipedia, de-identified Pittsburgh EHR and PubMed articles [31]. The 
top-performing systems used bidirectional long short-term memory (BiLSTM) with pre-trained 
word embeddings and a CRF layer for prediction. For example, Wunnava et al. [32] developed a 
three-layer neural network architecture, consisting of character-based BiLSTM, word-based 
BiLSTM and a CRF layer. They demonstrated that the integration of BiLSTM-CRF along with 
the character and word embeddings achieved excellent accuracy. Dandala et al. [33] developed a 
similar BiLSTM-CRF architecture but augmented concatenated character and word embeddings 
with part-of-speech embeddings. They observed the importance of features as well as pre-trained 
embeddings. 
There are several open source clinical NLP toolkits that can be used to extract information from 
electronic health record and clinical narratives. Such information could also be used as features 
for augmentation of word embeddings. cTAKES [34], for example, offers several analysis 
engines for various NLP and specific clinical tasks, such as event identification, terminology 
mapping, uncertainty detection, temporal expressions identification and extraction drug 
attributes. Similarly, CLAMP [35] contains several components to facilitate building customised 
pipelines for diverse clinical applications. 
MATERIALS AND METHODS 
Task 
The 2018 n2c2 task (track 2) focused on the extraction of several entity types: drugs, reason for 
taking a drug, route, frequency, dosage, strength, form, duration, and adverse events. Table 1 
provides detailed descriptions and examples for the entity types. We note that both ADE and 
Reason denote conditions, signs and symptoms observed in the patient. The Reason class denote 
conditions, signs and symptoms for which the drug was administered, while ADE denotes 
unwanted signs and symptoms that happened as a consequence of an administered drug. 
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Table 1: Descriptions of entity types in the shared task 
Entity type Description Examples 
Drug 
The product name of the drug or its chemical 
substance name.  
coumadin, vancomycin, 
aspirin, lasix, prednisone, o2, 
vitamin k, packed red blood 
cells 
Strength 
The amount of chemical substance of a drug 
in a given dosage. 
8.6 mg, 2.5 mg/3 ml 
(0.083%), 400 unit, 100 
unit/ml, 5% (700 mg/patch) 
Form The form in which a drug should be taken. 
Tablet, capsule, cream, tablet 
sustained release 24 hr 
Frequency 
The rate at which drug should be taken over a 
particular period of time. 
daily, prn, q4h (every 4 
hours) as needed, qid 
Route 
The way by which a drug should be taken or 
the location of absorbing a drug into the 
body. 
po, iv, by mouth, inhalation, 
p.o., topical, nasal, injection 
Dosage 
The amount of a drug that a patient should 
take. 
one (1), sliding scale, taper, 2 
units, 30 ml, 100 unit/ml,  
Reason 
The indication or reason for drug 
administration. 
pain, constipation, anxiety, 
nausea, wheezing, atrial 
fibrillation, pneumonia, 
hypotension 
ADE 
The development of unfavourable event due 
to a drug intake.  
rash, thrombocytopenia, 
toxicity, diarrhea, altered 
mental status 
Duration 
The length of a period of time during which a 
drug should be taken, 
for 7 days, for one week, 5 
days, few days, prn, 
chronically, until his ciwa 
was less than 10 
 
Dataset 
The dataset that was used for training and evaluation was provided as a part of the n2c2 shared-
task (track 2). The train set contained 303 labelled discharge letters with nine drug-related entities 
described in Table 1, and the test set included 202 documents. The documents were sampled as 
clinical care health records from MIMIC-III clinical care database [36]. MIMIC-III is a publicly-
available database comprising de-identified health-related data associated with approximately 
sixty thousand admissions of patients who stayed in critical care units of the Beth Israel 
Deaconess Medical Center between 2001 and 2012. The frequency of mentions for each entity 
type, as well as the average number of mentions per document and the average number of tokens 
per mention can be seen in Table 2. While the majority of classes in the train set had over 4,000 
mentions, we note that Duration and ADE had less than 1,000 instances each.  
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Table 2: Number of mentions, average mention per document and average number of tokens per 
mention for each of the entity types in the train and test sets 
Entity type 
Mentions Avg. mention/document Avg. token/mention 
train test train test train test 
Drug 16,225 10,583 53.55 52.39 1.22 1.21 
Strength 6,691 4,231 22.08 20.95 1.87 1.85 
Form 6,651 4,358 21.95 21.57 1.67 1.66 
Frequency 6,281 4,015 20.73 19.88 3.03 2.99 
Route 5,467 3,513 18.07 17.39 1.07 1.07 
Dosage 4,221 2,681 13.93 13.27 2.98 3.04 
Reason 3,855 2,559 12.72 12.67 1.80 1.81 
ADE 959 625 3.17 3.09 1.80 1.76 
Duration 592 380 1.95 1.88 2.66 2.58 
 
Neural network architectures for clinical entity recognition 
We propose two deep learning architectures for recognising drug-related named entities in 
clinical texts. Initially, text segments were separated into word (token) sequences and all class 
mentions were converted into label sequences using the IOB (inside-outside-beginning) tagging 
format. 
The word embedding layer transforms input raw words into vectors. The word representations 
were passed into the bidirectional recurrent neural network with long short-term memory units to 
learn important word-level features and transform them into the sequence label scores. The 
number of units for each RNN chain (i.e. backward and forward) was set to 70% of the input 
token representation size. The CRF layer is employed to optimize predictions across the whole 
sequence (i.e. text segment). Finally, the labels were combined into named entities by merging 
consecutively labelled B- or I- tags of the same class.  
In order to explore the effect of adding semantic features, we have created a variation of the 
word-only architecture described above. We augment the word representations with semantic 
feature representations extracted using the CLAMP and cTAKES clinical pipelines. After 
processing discharge summaries through the pipelines, we extracted all token-level semantic tags 
(i.e. problem, treatment, test, temporal, negation, severity degree, body location, change, 
uncertainty) with associated assertion tag attributes (i.e. present or absent) from CLAMP and all 
semantic tags (i.e. Medication, DiseaseDisorder, SignSymptom, AnatomicalSite, Procedure) from 
cTAKES. We have merged cTAKES and CLAMP semantic tags to create a comprehensive set of 
features. For each pipeline, words are tagged with the corresponding semantic tag and attribute (if 
available) or using outside (i.e. O) tag otherwise. A direct mapping of semantic tags extracted 
using clinical pipelines to target entities is not feasible, because certain entities (such as 
Frequency or Route) are not presented among semantic tags, while other semantic tags (such as 
SignSymptom or DiseaseDisorder) are too broad. Thereby, the representations of the semantic 
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tags could be learned simultaneously with word representations and concatenated together to 
form the final augmented token representations. The dimensionality of semantic representations 
has been set to 50. The architecture of the feature-augmented BiLSTM-CRF is presented in 
Figure 1. 
 
Figure 1: The architecture of the feature-augmented bidirectional LSTM with the CRF (BiLSTM-
CRF) label optimisation layer. Augmented embeddings consist of word embeddings and 
embeddings of semantic tags (extracted from CLAMP and cTAKES). 
Experiments 
We have utilised the unstructured corpus of ~2 million discharge summaries from MIMIC-III 
dataset to learn 100-dimensional word embeddings using word2vec skip-gram model. The 
word2vec is a widely used method to generate word embeddings, supporting two different 
architecture types that determine how the context of the word is modelled [23]. The skip-gram 
architecture performs better for infrequent words, compared to the continuous bag-of-words 
(CBOW) model [37]. In order to investigate the effect of pre-trained embeddings for both word-
only and feature-augmented BiLSTM-CRF architectures, we initialise the embedding layer 
weights with vectors from pre-trained word2vec embeddings and compared it with random 
vectors drawn from the uniform distribution [38]. To explore the efficiency of semantic features 
we performed feature-augmentation of both pre-trained and randomly initialised word vectors.  
All four models were trained using the RMSProp [39] optimisation algorithm. We have reserved 
10% of the data for validation and the number of epochs was determined by early stopping 
criteria (i.e. after 3 epochs with no improvement on the validation set). 
 
Evaluation methodology 
The primary evaluation metric for ranking systems in n2c2 challenge is the lenient micro-
averaged F1-score. The strict metric counts only exact entity matches as correct, whereas the 
lenient metric does not take into account entity boundaries, considering all partial matches 
 7 
(overlapping entities) as correct. To evaluate our models, we performed hold-out cross-validation 
(using training and testing sets). We reported lenient precision, recall and F1-score.  
 
RESULT 
The results of the lenient evaluation of word-only and feature-augmented (with semantic features 
obtained from CLAMP and cTAKES) BiLSTM-CRF models with randomly initialised 
embeddings are presented in Table 3.  
 
Table 3: The evaluation results of word-only and feature-augmented BiLSTM-CRF models with 
randomly initialised embeddings on the test set (202 documents) 
 
Word-only BiLSTM-CRF 
(random) 
Feature-augmented BiLSTM-CRF 
(random) 
Entity type Precision Recall F1-score Recall Precision F1-score 
Strength 97.25 96.10 96.67 97.12 96.41 96.76 
Frequency 96.83 95.07 95.94 96.81 94.60 95.69 
Form 96.95 93.44 95.16 97.38 92.89 95.08 
Route 97.19 92.63 94.85 96.60 93.14 94.84 
Drug 95.81 90.16 92.90 96.12 90.61 93.28 
Dosage 94.99 89.78 92.31 94.75 89.59 92.10 
Duration 80.99 72.89 76.73 84.08 73.68 78.54 
Reason 70.10 51.86 59.61 76.13 53.34 62.73 
ADE 52.86 19.20 28.17 50.24 33.92 40.50 
Overall (micro) 94.31 87.67 90.87 94.53 88.16 91.23 
Overall (macro) 94.01 86.03 89.62 93.74 86.28 89.65 
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Overall, the performance of the feature augmented model was better for five classes (Strength, 
Drug, Duration, Reason and ADE) compared to the word-only model, and the decrease for the 
remaining four classes (Frequency, Form, Route and Dosage) was between 0.01-0.25. However, 
the overall micro-averaged and macro-averaged F1-scores increased by 0.35 and 0.03 
respectively. Major increase was noticed for Reason and ADE classes (by 3.12 and 12.33 
respectively), potentially due to adding relevant semantic tags (e.g. DiseaseDisorder, 
SignSymptom, problem) from clinical pipelines. 
We presented two confusion matrices calculated on the token level for word-only and feature-
augmented BiLSTM-CRF models with randomly initialised embeddings in Figure 2. Each row of 
the confusion matrix is presenting the token instances of an actual class, whereas each column is 
presenting the token instances of a predicted class.  
 
Figure 2: Token-level confusion matrix of word-only and feature-augmented BiLSTM-CRF with 
randomly initialised embeddings. 
It can be seen that both word-only and feature-augmented models were confused between 
specific entity pairs. Namely, Dosage was incorrectly labelled as Strength and vice-versa; Form 
class has been often misclassified as Route, Drug or Dosage; ADE was confused with Reason, 
while Reason was mislabelled as Drug. An example of confusion between Strength and Dosage 
can be seen in the phrase “she received one litre of normal saline”, where it is hard (even for a 
human) to distinguish if “one litre” is a strength or dosage. A potential approach to resolve this 
would be adding rules specific for some entity types or to use more semantic features. 
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 Both Reason and ADE tokens were often not tagged as any entity class. In particular, over 60% 
of Reason tokens and over 80% of ADE tokens has been tagged as Outside class. Moreover, both 
entities usually describe diseases and symptoms, therefore there is a high confusion between 
them. The significant number of tokens (leading to about 6% of token-level recall loss) that were 
supposed to be tagged as ADE were misclassified as Reason. While the most confusing entity 
class for Reason was Drug. This potentially could happen because in some cases the indication 
(i.e. reason to take a drug) is included in the Drug entity (e.g. “pain medications”, “anti-seizure 
medication”). By adding feature-augmentation, we observed an increase in the number of true 
positives for both ADE and Reason classes, in particular for ADE the increase was 80%. 
However, it had a negative impact on the number of true positive matches for Frequency class.  
The results of the lenient evaluation of word-only and feature-augmented BiLSTM-CRF models 
with pre-trained word embeddings on MIMIC-III are presented in Table 4.  
 
Table 4: The evaluation results of word-only and feature-augmented BiLSTM-CRF models with 
pre-trained MIMIC-III embeddings on the test set (202 documents) 
Entity type 
Word-only BiLSTM-CRF  
(MIMIC-III) 
Feature-augmented BiLSTM-CRF 
(MIMIC-III) 
Precision Recall F1-score Precision Recall F1-score 
Strength 96.96 98.06 97.51 97.87 97.75 97.81 
Frequency 96.97 95.86 96.42 96.66 96.06 96.36 
Form 96.94 93.65 95.26 97.02 93.99 95.48 
Route 95.66 94.22 94.94 96.47 94.22 95.33 
Drug 95.06 94.96 95.01 96.26 94.28 95.26 
Dosage 93.63 93.17 93.40 93.22 93.36 93.29 
Duration 82.23 85.71 83.94 86.03 81.48 83.70 
Reason 63.90 63.58 63.74 73.88 59.02 65.62 
ADE 45.97 45.60 45.78 69.30 36.48 47.80 
Overall (micro) 92.23 91.60 91.91 94.56 90.85 92.67 
Overall (macro) 91.70 90.62 91.03 94.36 89.89 91.96 
 
 
The performance increased for all entity types when embedding layer weights were initialised 
with vectors from MIMIC-III pre-trained word2vec embeddings. For the word-only model, the 
overall micro-averaged F1-score was 91.91 (compared to 90.87) and the feature-augmented 
model yielded 92.67 (compared to 91.23). 
 
As noted in Table 4, the performance of the feature-augmented model was better for most of the 
classes compared to the word-only model, increasing both micro- and macro-averaged F1-scores 
by 0.76 and 0.93 respectively. Similarly, to randomly initialised models, for context-sensitive 
classes, such as Reason and ADE the F1-score increased by 1.88 and 2.02 respectively. However, 
for Frequency, Dosage and Duration, the performance dropped by less than 0.25.  
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In Figure 3 we presented two token-level confusion matrices for word-only and feature-
augmented models with pre-trained word embeddings.  We noticed that patterns in confusion 
between classes are similar to what we observed with randomly initialised models (Figure 2). 
 
 
Figure 3: Token-level confusion matrix for word-only and feature-augmented (using CLAMP and 
cTAKES semantic tags) BiLSTM-CRF with pre-trained word embeddings on MIMIC-III. 
As seen in Table 3 and 4, both word-only and feature-augmented architectures perform well 
achieving high precision, recall and F1-score (over 90%) for most of the classes except Duration, 
Reason and ADE.  As noted in Table 2, Duration was the least frequent class in the dataset with 
only 592 instances. This potentially could have a negative impact on the performance, therefore, 
given more data, the performance would likely increase. We also observed from Table 3 and 4 – 
similarly to previous studies (e.g. [32]) – that Reason and ADE underperform due to their 
similarity (both denote conditions, signs and symptoms) – see confusion matrices (Figure 2 and 
3). The difference is in the context in which they are mentioned, which can be challenging for a 
neural network to learn in particular as ADE was relatively infrequent. 
 
The augmentation of word embeddings with semantic features demonstrated a slight increase in 
overall micro-averaged F1-score for clinical entity extraction. However, there were small 
differences between scores achieved by top-performing systems submitted to the n2c2 entity 
extraction task. The feature-augmented BiLSTM-CRF model with pre-trained word embeddings 
was ranked 4th among 30 teams. The system ranked 1st achieved micro-averaged overall F1-score 
of 94.18% (1.51% more than described system), while the system ranked as 10th yielded 91.4% 
(1.27% less than our system).  
CONCLUSION 
In this paper, we have described a recurrent neural network architecture that can be used for 
monitoring drug administration and potential adverse drug events in discharge summaries. In 
order to capture semantic regularities in the clinical language, word embeddings were pre-trained 
on a large unstructured corpus of clinical texts from the MIMIC-III database. Such embeddings 
have a comprehensive vocabulary which includes various synonyms and spelling variations of 
words. Therefore, the entity recognition model that utilise them is much less prone to overfitting 
and would require less labelled data to reach state-of-the-art performance. We have also 
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examined the effects of augmenting word vectors with semantic features extracted using the 
CLAMP and cTAKES clinical pipelines. The evaluation results show that such augmentation 
generally improves the performance regardless of embedding initialisation method, especially for 
specific entity types such as ADE and Reason (for both lenient and strict scores was observed the 
same pattern of changes). 
We also have noticed a few inconsistencies in the annotated dataset that might have contributed 
to the errors. One of the common errors appears when our model is annotating entities that are 
missing in the gold standard dataset. For example, the "three days" in the phrase "adding DRUG 
cover for the first three days of treatment" is not annotated as Duration in the gold standard while 
it seems to be an appropriate duration. There are also a few examples where the entities are 
annotated in various ways in the gold standard. For example, the word “injection” has been 
annotated as a Form in some cases and as a Route in others. Inconsistencies may also appear in 
annotation spans (e.g., annotating a Dosage or Strength and Form separately in some case and 
jointly in others). 
Future work could involve the investigation of other types of features commonly used in clinical 
entity recognition, such as part-of-speech tags, regular expressions and external gazetteers. To 
address the issue related to confusion between ADE and Reason entities, ontologies containing 
information about common indications of drugs and their known adverse events could be utilised. 
Also, available historical patient-specific EHR metadata (i.e. data extracted from EHRs for a 
particular patient), such as medical conditions, previously prescribed drugs and experienced 
ADRs could add an extra layer of details that could boost the performance of entity recognition. 
Since 2018, a number of novel contextualised word representation models were published, such 
as ELMo [40], GPT-2 [41], BERT [42], ERNIE [43]. These models utilize deeper architectures to 
represent both context and knowledge about entities more efficiently. Fine-tuning these language 
models for a given domain (i.e. discharge summaries) and task (i.e. clinical entity extraction) has 
a potential to further improve the entity extraction performance. However, pre-training or fine-
tuning these models may be both resource and time intensive.  
Moving further from entity recognition, relationships between such entities can be extracted to 
associate drugs with the correct context. Relationship extraction can be reduced to a classification 
task and similar architectures based on feature-augmented recurrent neural network can be 
applied (i.e. representing a context of relation as a sequence of words between participating 
entities and then instead of labelling each word in a sequence, the output will be aggregated to 
predict a relation type for the whole sequence). The combination of entity recognition and 
relation extraction can enable a full-scale end-to-end drug monitoring system and further 
statistical analysis of extracted information, potentially leading to reducing the cost and 
improving the quality of monitoring drug administration and adverse drug events. 
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